Legal Representation
Attorney
Chad Wiegand
USPTO Deadlines
Next Deadline
852 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-11-27)
Due Date
November 27, 2027
Grace Period Ends
May 27, 2028
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 4, 2014 | C8.. | O | CANCELLED SEC. 8 (6-YR) | Loading... |
| Nov 27, 2007 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 23, 2007 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED | Loading... |
| Oct 9, 2007 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Aug 24, 2007 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jul 13, 2007 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 13, 2007 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jul 3, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 10, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 21, 2007 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Feb 23, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 21, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 21, 2007 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Feb 21, 2007 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 24, 2007 | I | PAPER RECEIVED | Loading... | |
| Jan 24, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 1, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 1, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 1, 2006 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 16, 2006 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Feb 15, 2006 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | Loading... |
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"Therapeutics, Inc."